| scholarly article | Q13442814 |
| P2093 | author name string | Donghee Kim | |
| Goh Eun Chung | |||
| Min-Sun Kwak | |||
| Yoon Jun Kim | |||
| Hyo-Suk Lee | |||
| Jung-Hwan Yoon | |||
| Min Jung Park | |||
| Seung Joo Kang | |||
| P2860 | cites work | Biliverdin reductase: a major physiologic cytoprotectant | Q24541497 |
| Bilirubin is an antioxidant of possible physiological importance | Q28288206 | ||
| A cohort study of serum bilirubin levels and incident non-alcoholic fatty liver disease in middle aged Korean workers | Q28729949 | ||
| Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity | Q29614932 | ||
| Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement | Q29619465 | ||
| High Total Bilirubin as a Protective Factor for Diabetes Mellitus: An Analysis of NHANES Data From 1999 - 2006 | Q33918067 | ||
| Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association | Q34112671 | ||
| Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels | Q34114552 | ||
| Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study | Q34501554 | ||
| Association between the UGT1A1*28 allele, bilirubin levels, and coronary heart disease in the Framingham Heart Study. | Q34568821 | ||
| Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference | Q35115696 | ||
| The role of bilirubin in diabetes, metabolic syndrome, and cardiovascular diseases | Q35867073 | ||
| Antioxidant activities of bile pigments | Q35877590 | ||
| Serum total bilirubin level, prevalent stroke, and stroke outcomes: NHANES 1999-2004. | Q37001252 | ||
| A central role of heme oxygenase-1 in cardiovascular protection | Q37810954 | ||
| Heme oxygenase-1 protects against steatohepatitis in both cultured hepatocytes and mice | Q39789155 | ||
| Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities | Q43552270 | ||
| Oxidative stress in the pathogenesis of nonalcoholic fatty liver disease, in rats fed with a choline-deficient diet. | Q44205243 | ||
| Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States | Q44269254 | ||
| A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis | Q44907394 | ||
| The relation between non-alcoholic fatty liver disease and the risk of coronary heart disease in Koreans. | Q45985039 | ||
| Serum bilirubin distribution and its relation to cardiovascular risk in children and young adults | Q46157669 | ||
| Free radical-induced liver injury. II. Effects of intraperitoneally administered 2,2'-azobis(2-amidinopropane) dihydrochloride on the fatty acid profiles of hepatic triacylglycerol and phospholipids | Q46694970 | ||
| Clinicopathological significance of oxidative cellular damage in non-alcoholic fatty liver diseases | Q46731176 | ||
| Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease. | Q51034508 | ||
| Unconjugated hyperbilirubinemia is inversely associated with non-alcoholic steatohepatitis (NASH). | Q51357634 | ||
| Relationship between nonalcoholic fatty liver disease and metabolic syndrome. | Q51377176 | ||
| Damage to biological tissues induced by radical initiator 2,2'-azobis(2-amidinopropane) dihydrochloride and its inhibition by chain-breaking antioxidants. | Q52493699 | ||
| Influence of sex and sex steroids on bilirubin uridine diphosphate-glucuronosyltransferase activity of rat liver | Q70484657 | ||
| Association of low serum concentration of bilirubin with increased risk of coronary artery disease | Q72722527 | ||
| Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease | Q78654225 | ||
| Serum bilirubin is inversely associated with insulin resistance and metabolic syndrome among children and adolescents | Q81937467 | ||
| Unconjugated hyperbilirubinemia in patients with non-alcoholic fatty liver disease: a favorable endogenous response | Q83133390 | ||
| Fatty liver induced by free radicals and lipid peroxidation | Q83790840 | ||
| Nonalcoholic fatty liver disease: The hepatic trigger of the metabolic syndrome | Q84980641 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | liver disease | Q929737 |
| metabolic dysfunction–associated steatotic liver disease | Q1546498 | ||
| fatty liver disease | Q6058862 | ||
| P304 | page(s) | 383-390 | |
| P577 | publication date | 2012-12-21 | |
| P1433 | published in | Clinical and molecular hepatology | Q26853927 |
| P1476 | title | Serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease | |
| P478 | volume | 18 |
| Q87638954 | A Novel Fluorescence-Based Assay for the Measurement of Biliverdin Reductase Activity |
| Q37154805 | Association between bilirubin and risk of Non-Alcoholic Fatty Liver Disease based on a prospective cohort study |
| Q35987425 | Bilirubin Binding to PPARα Inhibits Lipid Accumulation |
| Q50154845 | Bilirubin in the Liver-Gut Signaling Axis |
| Q64897924 | Bilirubin, a new therapeutic for kidney transplant? |
| Q46171319 | Biliverdin Reductase A Attenuates Hepatic Steatosis by Inhibition of Glycogen Synthase Kinase (GSK) 3β Phosphorylation of Serine 73 of Peroxisome Proliferator-activated Receptor (PPAR) α. |
| Q52679682 | Biliverdin Reductase and Bilirubin in Hepatic Disease. |
| Q33693385 | Does bilirubin prevent hepatic steatosis through activation of the PPARα nuclear receptor? |
| Q60949670 | Genetically Regulated Bilirubin and Risk of Non-alcoholic Fatty Liver Disease: A Mendelian Randomization Study |
| Q89820673 | Heme-Derived Metabolic Signals Dictate Immune Responses |
| Q37232122 | Hepatic function and the cardiometabolic syndrome |
| Q92219736 | Hepatoprotective Effects of a Ruthenium(II) Schiff Base Complex in Rats with Diet-Induced Prediabetes |
| Q46237033 | Hepatoprotective effect of calculus bovis sativus on nonalcoholic fatty liver disease in mice by inhibiting oxidative stress and apoptosis of hepatocytes. |
| Q38424367 | Looking to the horizon: the role of bilirubin in the development and prevention of age-related chronic diseases |
| Q52431412 | Loss of biliverdin reductase-A (BVRA) promotes lipid accumulation and lipotoxicity in mouse proximal tubule cells. |
| Q46225090 | Mice with hyperbilirubinemia due to Gilbert's syndrome polymorphism are resistant to hepatic steatosis by decreased serine 73 phosphorylation of PPARα. |
| Q53695403 | Non-Alcoholic Fatty Liver Disease and Associated Factors among Type 2 Diabetic Patients in Southwest Ethiopia. |
| Q38164074 | Non-alcoholic fatty liver disease: factors associated with its presence and onset |
| Q92921833 | Plasma Krebs Cycle Intermediates in Nonalcoholic Fatty Liver Disease |
| Q33886918 | Proteomic and genomic studies of non-alcoholic fatty liver disease--clues in the pathogenesis |
| Q99604869 | Rats Genetically Selected for High Aerobic Exercise Capacity Have Elevated Plasma Bilirubin by Upregulation of Hepatic Biliverdin Reductase-A (BVRA) and Suppression of UGT1A1 |
| Q36330434 | Relationship between serum bilirubin concentrations and diabetic nephropathy in Shanghai Han's patients with type 1 diabetes mellitus |
| Q48006787 | Systemic regulation of bilirubin homeostasis: Potential benefits of hyperbilirubinemia |
| Q91928199 | Western Diet-Induced Metabolic Alterations Affect Circulating Markers of Liver Function before the Development of Steatosis |
Search more.